SCHEMBL16620107

SCHEMBL16620107

CC(C)(C)OC(=O)N1C(Cc2ccc(C(=O)O)cc2)CCC1C(O[Si](C)(C)C(C)(C)C)c1ccc(Cl)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ATM Q13315 1/20 0.34
CNR1 P21554 6/20 0.33
PDE5A O76074 1/20 0.33
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32
NR1D1 P20393 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
CETP P11597 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16620104 1.00 NPSR1 (0.36) NPSR1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL18017432 1.00 NPSR1 (0.36) NPSR1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL21278208 1.00 NPSR1 (0.36) NPSR1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL18210810 0.92 KDM4E (0.35) SMN1; SMN2THRBCETPGAA
SCHEMBL18017423 0.92 KDM4E (0.35) SMN1; SMN2THRBCETPGAA
SCHEMBL18210805 0.92 KDM4E (0.35) SMN1; SMN2THRBCETPGAA
SCHEMBL9933127 0.92 KDM4E (0.35) SMN1; SMN2THRBCETPGAA
SCHEMBL9933123 0.92 KDM4E (0.35) SMN1; SMN2THRBCETPGAA
SCHEMBL16619897 0.92 HDAC1 (0.40) NPSR1SMN1; SMN2HTTMEN1KMT2A
SCHEMBL17986575 0.92 HDAC1 (0.40) NPSR1SMN1; SMN2HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed